FS
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol | Pharmaceuticals |  | 2023 | 63 | 32 | ||
| Physiologically-based pharmacokinetic modeling for the prediction of CYP2D6-mediated gene-drug-drug interactions | CPT: pharmacometrics & systems pharmacology | | 2019 | 405 | 276 | ||
| Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives | Clinical Pharmacokinetics | | 2018 | 516 | 724 | ||
| Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomes | Basic & Clinical Pharmacology & Toxicology | | 2018 | 509 | 548 | ||
| Understanding and predicting the association of intrinsic and extrinsic factors of pharmacokinetic variability in the context of precision medicine: impact of genetic polymorphisms on CYP2D6-mediated drug-drug interactions |  | 2018 | 765 | 35 | |||
| Impact of CYP2D6 functional allelic variations on phenoconversion and drug-drug interactions | Clinical Pharmacology and Therapeutics | | 2017 | 493 | 5 | ||
| The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Pharmacology | | 2017 | 617 | 240 | ||
| Pharmacogenomics of Oral Antithrombotic Drugs | Current pharmaceutical design | 2016 | 620 | 0 | |||
| The effect of proton pump inhibitors on platelet activity: An ex-vivo study | | 2012 | 304 | 18 |
